ODAC unanimously backed the use of highly sensitive tests that check for minimal residual disease to speed up drug approvals for multiple myeloma.MDedge News (Source: Medscape Medical News Headlines)
My WordPress Blog
ODAC unanimously backed the use of highly sensitive tests that check for minimal residual disease to speed up drug approvals for multiple myeloma.MDedge News (Source: Medscape Medical News Headlines)